MHRA: Maintains Public Human Medicines Export Certificate Register

• The Medicines and Healthcare products Regulatory Agency (MHRA) and the Department of Health and Social Care maintain a register of electronic export certificates for human medicines.
• This register is updated monthly, with records currently available from September 2025 through August 2026.
• Each monthly register is provided in multiple formats, including PDF, MS Excel Spreadsheet, and HTML.
• PDF documents range from 7 to 12 pages and up to 274 KB, while Excel files are up to 28.3 KB.
• The register serves as a critical resource for verifying UK pharmaceutical export certificates and ensuring compliance.

For legal professionals and compliance officers advising pharmaceutical companies engaged in international trade, the register provides an authoritative source for verifying the issuance of necessary export documentation.

The Medicines and Healthcare products Regulatory Agency (MHRA), in collaboration with the Department of Health and Social Care, actively maintains a publicly accessible MHRA human medicines export certificate register. This crucial resource serves as a comprehensive record of electronic export certificates that have been officially issued for human medicines. Its establishment and ongoing upkeep highlight the regulatory bodies' commitment to transparency and stringent oversight within the pharmaceutical export sector. The register provides a centralized, authoritative source for information concerning UK pharmaceutical export certificates, playing a pivotal role in the broader framework of international trade compliance for medicinal products originating from Great Britain.

The MHRA electronic export documentation is meticulously updated on a monthly basis, ensuring that stakeholders have access to the most current information. The register currently encompasses records spanning a significant period, from September 2025 through August 2026. To cater to diverse user needs and technical capabilities, each monthly iteration of the register is made available in multiple digital formats. These include readily viewable PDF documents, structured MS Excel Spreadsheets for data analysis, and accessible HTML versions for direct web browsing.

The PDF files vary in their specifications; for instance, the August 2026 PDF is 231 KB and comprises 9 pages, while the March 2026 PDF is larger at 274 KB and contains 12 pages. Similarly, the MS Excel Spreadsheet files also show variation, with the August 2026 version being 24.3 KB and the March 2026 version slightly larger at 27.9 KB. These varied formats underscore the effort to provide comprehensive and usable data for Human medicines export register UK users.

This publicly available MHRA human medicines export certificate register represents an indispensable tool for ensuring robust GB human medicines export compliance. For legal professionals and compliance officers advising pharmaceutical companies engaged in international trade, the register provides an authoritative source for verifying the issuance of necessary export documentation. It significantly streamlines Pharmaceutical export due diligence GB processes by enabling stakeholders to confirm the authenticity and validity of electronic export certificates.

This verification capability is critical for mitigating potential legal and commercial risks associated with the international movement of pharmaceutical products. The consistent and transparent provision of these records by the MHRA supports the development and maintenance of strong compliance frameworks across the entire pharmaceutical supply chain, reinforcing trust and regulatory adherence in global markets.

Lawyers and compliance officers advising pharmaceutical companies on UK export regulations should utilize this MHRA register as a critical resource for verifying the issuance of electronic export certificates for human medicines. This ensures ongoing compliance and facilitates due diligence in international trade.

Source: Original reporting via GOV.UK